Close Menu
Royalty Pharma Buys Portion of NWU’s Royalty Interest in Lyrica for $700M
 
Royalty Pharma and Northwestern University said this month that Northwestern has sold an undisclosed portion of its royalty interest in Lyrica to Royalty Pharma for $700 million in cash.
 
The one-time payment is considered one of the largest royalty monetization deals ever related to an invention spawned from university research.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.